Výsledky vyhledávání - "Marame Hamila"

Akademický článek

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

Autor: Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, Brice Thamphya, Marame Hamila, Henri Montaudié, Alexandra Picard-Gauci, Sophie Gardrat, Thierry Passeron, Sandra Lassalle, Elodie Long-Mira, Julien Cherfils-Vicini, Eric Gilson, Véronique Hofman, Paul Hofman

Publikováno v: OncoImmunology, Vol 10, Iss 1 (2021)

The outcome of patients with cutaneous melanoma has been strongly modified by recent advances obtained with Immune Checkpoint Inhibitors (ICIs). However, despite this breakthrough, durable response to ICIs is limited to a subset of patients. We inves

Externí odkaz: https://doaj.org/article/bfd4f825455c4ae1a40fb600d495b127

Zobrazit plný text záznamu

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

Autor: Marius Ilié, Jonathan Benzaquen, Paul Tourniaire, Simon Heeke, Nicholas Ayache, Hervé Delingette, Elodie Long-Mira, Sandra Lassalle, Marame Hamila, Julien Fayada, Josiane Otto, Charlotte Cohen, Abel Gomez-Caro, Jean-Philippe Berthet, Charles-Hugo Marquette, Véronique Hofman, Christophe Bontoux, Paul Hofman

Publikováno v: Cancers; Volume 14; Issue 7; Pages: 1740
Cancers
Cancers, 2022, 14 (7), pp.1740. ⟨10.3390/cancers14071740⟩

International audience; The histological distinction of lung neuroendocrine carcinoma, including small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC) and atypical carcinoid (AC), can be challenging in some cases, while bearin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa43bfa52b661c8004e7d627b9773fd4
https://pubmed.ncbi.nlm.nih.gov/35406511

Zobrazit plný text záznamu

Plný text ve formátu HTML

Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer

Autor: Marius Ilié, Mélanie Beaulande, Elodie Long-Mira, Christophe Bontoux, Katia Zahaf, Salomé Lalvée, Marame Hamila, Jonathan Benzaquen, Charlotte Cohen, Jean-Philippe Berthet, Charles-Hugo Marquette, Sandra Lassalle, Véronique Hofman, Paul Hofman

Publikováno v: Lung cancer (Amsterdam, Netherlands). 166

The evaluation of an increasing number of diagnostic and predictive markers is playing a central role in precision thoracic oncology. Multiplex immunohistochemistry (mIHC), alongside next-generation sequencing, is ideally situated for this purpose an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8afc5d3919679eed727c2b7bdaa2da93
https://pubmed.ncbi.nlm.nih.gov/35134710

Zobrazit plný text záznamu

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

Autor: Emmanuel Chamorey, Paul Hofman, Henri Montaudié, Brice Thamphya, Marius Ilie, Sandra Lassalle, Marame Hamila, Alexandra Picard-Gauci, Thierry Passeron, Sophie Gardrat, Eric Gilson, Véronique Hofman, Julien Cherfils-Vicini, Elodie Long-Mira, Elisabeth Lantéri

Publikováno v: Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1901446. ⟨10.1080/2162402X.2021.1901446⟩

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121811f4b0f3cd1f8e7e836f3d2ccb22
https://pubmed.ncbi.nlm.nih.gov/33796413

Zobrazit plný text záznamu

Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France)

Publikováno v: Biopreservation and biobanking. 18(6)

In only a few months after its inception, the COVID-19 pandemic lead to the death of hundreds of thousands of patients and to the infection of millions of people on most continents, mostly in the United States and in Europe. During this crisis, it wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada4db8311bc57cbd84d10e9eb4351b6
https://pubmed.ncbi.nlm.nih.gov/33175565

Zobrazit plný text záznamu

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?

Autor: Marius Ilie, Elodie Long-Mira, Véronique Hofman, Sandra Lassalle, Eric Tartour, Cécile Badoual, Léa Berland, Paul Hofman, Hélène Roussel, Fiona Henderson, Marame Hamila

Publikováno v: Cancers
Cancers, Vol 11, Iss 3, p 283 (2019)

As targeted molecular therapies and immuno-oncology have become pivotal in the management of patients with lung cancer, the essential requirement for high throughput analyses and clinical validation of biomarkers has become even more intense, with re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f474011c6e699041d6e71ff97940840
http://europepmc.org/articles/PMC6468415

Zobrazit plný text záznamu

Plný text ve formátu HTML

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Autor: Marame Hamila, Sandra Lassalle, Catherine Butori, Véronique Hofman, Paul Hofman, Marius Ilie, Coraline Bence, Mélanie Ngo-Mai, Elodie Long-Mira

Publikováno v: J Vis Exp

Pembrolizumab monotherapy has been approved for the first- and second-line treatment of patients with PD-L1-expressing advanced non-small cell lung cancer (NSCLC). Testing for PD-L1 expression with the PD-L1 immunohistochemistry (IHC) 22C3 companion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0b072a352ac273a969bb2c31702574
https://pubmed.ncbi.nlm.nih.gov/30320751

Zobrazit plný text záznamu

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer

Autor: Marame Hamila, Véronique Hofman, Mélanie Beaulande, Marius Ilie, Paul Hofman, Gilles Erb

Publikováno v: Lung cancer (Amsterdam, Netherlands). 124

Objectives The current challenge in the management of non-small cell lung cancer (NSCLC) in pathology laboratories is to combine immunohistochemistry (IHC) and molecular approaches on increasingly smaller biopsies and the need to reserve a fair amoun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0ced524a5ed2503b94f6c7762280ca9
https://pubmed.ncbi.nlm.nih.gov/30268486

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání